Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Bonn

Botulinumtoxin-Therapie

Off Label Use of Botulinum Toxin in Children under Two Years of Age: A Systematic Review

Druschel C, Althuizes HC, Funk JF, Placzek R. Off Label Use of Botulinum Toxin in Children under Two Years of Age: A Systematic Review. Toxins. 2013;5(1):60-72. PubMed PMID: 23296386.

Botulinum toxin A in children with infantile cerebral palsy: indications and treatment concepts

Placzek R. [Botulinum toxin A in children with infantile cerebral palsy: indications and treatment concepts]. Der Orthopade. 2010 Jan;39(1):23-30. PubMed PMID: 20033394. Botulinumtoxin A bei Kindern mit infantiler Zerebralparese: Indikationen und Anwendungskonzepte.

The key-muscle concept: a long-term low-dose injection strategy for botulinum toxin A treatment in cerebral palsy

Placzek R, Salem KH, Meiss LA, Siebold D, Drescher W. The key-muscle concept: a long-term low-dose injection strategy for botulinum toxin A treatment in cerebral palsy. Acta orthopaedica Belgica. 2012 Feb;78(1):111-6. PubMed PMID: 22523937.

Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy

Placzek R, Siebold D, Funk JF. Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy. Toxins. 2010 Sep;2(9):2258-71. PubMed PMID: 22069684. Pubmed Central PMCID: 3153296.

Zurück